Nasdaq

Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform

- First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes - Abbott and eMed™ expect to deliver and administer 30 ...
FierceBiotech

Abbott plans to ship tens of millions of $25, at-home coronavirus tests in early 2021

Earlier this year, Abbott unveiled a cheap coronavirus diagnostic contained entirely on a paper booklet the size of a credit card, designed to deliver a reading within 15 minutes. Paired with its ...
WMUR

Hundreds of thousands of rapid COVID-19 tests on way to New Hampshire

A SMART PHONE APP CALLED NAVICA, AND IT CAN CERTIFY TO AN EMPLOYER OR A COACH OR A SCHOOL THE DATE AND TIME OF A NEGATIVE COVID TEST. ADM. GIROIR: IF THERE IS O PINK LINE, YOU ARE NEGATIVE. IF THERE ...
Nasdaq

Abbott Announces Fulfillment of Federal Government Purchase of 150 Million BinaxNOW™ COVID-19 Rapid Tests and Is Now Ready to Support Commercial Distribution

- Abbott has the most advanced and comprehensive COVID-19 rapid test portfolio available today, including ID NOW, BinaxNOW, the BinaxNOW at-home test and the NAVICA app - Workplaces, universities, ...